V3 TRANSVAGINAL NOTES-ASSISTED LAPAROSCOPIC LIVING DONOR NEPHRECTOMY

Antonio Alcaraz(Hospital Clínic de Barcelona), M.J. Ribal, Marta Piqueras(Universitat de València), Mireía Musquera(Surgical Specialties (Canada)), Lluís Peri(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)

European Urology Supplements

March 26, 2010

10.1016/s1569-9056(10)61040-8

Cited by 0

Related Papers

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

|The Lancet Oncology|2009|196

Robot-assisted Kidney Transplantation: The European Experience

|European Urology|2017|143

Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma

|Journal of Clinical Oncology|2010|130

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

|Clinical Cancer Research|2014|100

Feasibility of Transvaginal Natural Orifice Transluminal Endoscopic Surgery–Assisted Living Donor Nephrectomy: Is Kidney Vaginal Delivery the Approach of the Future?

|European Urology|2011|92